In vivo activation of a mutant opioid opioid opioid receptor by antagonist : Future direction for opiate pain treatment paradigm that lacks undesirable side effects

@inproceedings{Law2003InVA,
  title={In vivo activation of a mutant opioid opioid opioid receptor by antagonist : Future direction for opiate pain treatment paradigm that lacks undesirable side effects},
  author={P C Law and Jesse W. Yang and Xiaohong Guo and Horace H. Loh},
  year={2003}
}
CELL BIOLOGY. For the article ‘‘Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPAR agonist,’’ by Thomas M. McIntyre, Aaron V. Pontsler, Adriana R. Silva, Andy St. Hilaire, Yong Xu, Jerald C. Hinshaw, Guy A. Zimmerman, Kotaro Hama, Junken Aoki, Hiroyuki Arai, and Glenn D. Prestwich, which appeared in… CONTINUE READING